Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) Ending Cash Position: ₺79 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

IST:GENIL Gen Ilac Ve Saglik Urunleri Sanayi ve Ticaret AS IST:GENIL
86 GF Score
Price ₺11.39
GF Value ₺8.27
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Gen Ilac Veglik Urunlerinayi ve Ticaret AS Ending Cash Position?

Gen Ilac Veglik Urunlerinayi ve Ticaret AS IST:GENIL +5.86% 86 Ending Cash Position is ₺79 Mil as of Jun. 2026. GuruFocus rates IST:GENIL with a GF Score™ of 86/100 and a GF Value™ of ₺8.27 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Ending Cash Position for the quarter that ended in Jun. 2026 was ₺79 Mil.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's quarterly Ending Cash Position increased from Dec. 2025 (₺94 Mil) to Mar. 2026 (₺275 Mil) but then declined from Mar. 2026 (₺275 Mil) to Jun. 2026 (₺79 Mil).

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's annual Ending Cash Position increased from Dec. 2023 (₺97 Mil) to Dec. 2024 (₺711 Mil) but then declined from Dec. 2024 (₺711 Mil) to Dec. 2025 (₺94 Mil).

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Ending Cash Position Related Terms

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Ending Cash Position Chart

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
Get a 7-Day Free Trial 519.44 644.70 97.25 710.71 93.97

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 576.09 416.73 93.97 275.45 79.44
IST:GENIL
86GF Score
Gen Ilac Ve Saglik Urunleri Sanayi ve Ticaret AS IST:GENIL
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=589.612+-495.643
=94

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Ending Cash Position for the quarter that ended in Jun. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=282.698+-203.263
=79

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of ₺79 Mil mean?
Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) has a Ending Cash Position of ₺79 Mil as of Jun. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Gen Ilac Veglik Urunlerinayi ve Ticaret AS and its competitors.
Is Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Ending Cash Position too high?
Gen Ilac Veglik Urunlerinayi ve Ticaret AS's current Ending Cash Position is ₺79 Mil. Overall, Gen Ilac Veglik Urunlerinayi ve Ticaret AS has a GF Score™ of 86/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Ending Cash Position compare to ZTS and UTHR?
Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Ending Cash Position of ₺79 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Drug Manufacturers company?
A good Ending Cash Position depends on the Drug Manufacturers industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Gen Ilac Veglik Urunlerinayi ve Ticaret AS and its competitors. Gen Ilac Veglik Urunlerinayi ve Ticaret AS's current Ending Cash Position is ₺79 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gen Ilac Veglik Urunlerinayi ve Ticaret AS stock overvalued right now?
Based on GuruFocus' analysis, Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) is currently considered Significantly Overvalued. The stock's GF Value™ is ₺8.27, compared to a current price of ₺11.39 — trading 37.7% above its estimated fair value. The current Ending Cash Position is ₺79 Mil. Gen Ilac Veglik Urunlerinayi ve Ticaret AS's overall GF Score™ is 86/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL), the current Ending Cash Position is ₺79 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) Overvalued in 2026?

Based on GuruFocus' analysis, Gen Ilac Veglik Urunlerinayi ve Ticaret AS stock appears to be overvalued. The current stock price of ₺11.39 is trading 37.7% above its estimated GF Value™ of ₺8.27. GuruFocus considers Gen Ilac Veglik Urunlerinayi ve Ticaret AS to be Significantly Overvalued.

Key valuation signals for IST:GENIL:

  • Ending Cash Position: ₺79 Mil
  • GF Value™: ₺8.27 vs. price of ₺11.39 (37.7% above fair value)
  • GF Score™: 86/100 with 4 warning signs

No single metric tells the full story. See the IST:GENIL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Business Description

Address Mustafa Kemal Mahallesi 2119.Sk. No:3, Cankaya, Ankara, TUR, 06520
Gen Ilac Ve Saglik Urunleri Sanayi ve Ticaret AS is a specialty pharmaceuticals company in Turkey. Its locally manufactured products include Cajex, Contra-K, Epamor, Genkort, Ilopera, among others, while imported products include AvonexPEN, Plegridy, Tecfidera, Regen-D among others.
86GF Score

Get the complete analysis for IST:GENIL

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₺11.39
Price
₺8.27
GF Value